tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TATA Health Faces Extended Trading Suspension Amid Compliance Review

Story Highlights
TATA Health Faces Extended Trading Suspension Amid Compliance Review

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from TATA Health International Holdings Ltd. ( (HK:1255) ) is now available.

TATA Health International Holdings Limited, listed on the Hong Kong Stock Exchange, has announced additional guidance for the resumption of trading in its shares. The company is required to conduct an independent internal control review to ensure compliance with the Listing Rules. Trading in the company’s shares has been suspended since April 2024 and will remain so until the resumption guidance is fulfilled. The company is responsible for devising an action plan to address the issues causing the suspension and will keep the public informed of developments.

More about TATA Health International Holdings Ltd.

Technical Sentiment Signal: Sell

Current Market Cap: HK$72.85M

See more data about 1255 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1